Lantern Pharma, Inc. (LTRN)
3.32
-0.06
(-1.78%)
USD |
NASDAQ |
May 27, 16:00
3.32
0.00 (0.00%)
After-Hours: 20:00
Lantern Pharma Free Cash Flow : -15.07M for March 31, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| BioVie, Inc. | -20.51M |
| Vertex Pharmaceuticals, Inc. | 3.710B |
| Spero Therapeutics, Inc. | 7.242M |
| Replimune Group, Inc. | -283.27M |
| Acurx Pharmaceuticals, Inc. | -6.144M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -3.773M |
| Cash from Investing (Quarterly) | 4.25M |
| Free Cash Flow Per Share (Quarterly) | -0.3353 |
| Free Cash Flow to Equity (Quarterly) | -3.753M |
| Free Cash Flow to Firm (Quarterly) | -3.773M |
| Free Cash Flow Yield | -41.16% |